Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
NVST 
Envista Holdings Corp (NVST)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: NVST (1-star) is a SELL. SELL since 4 days. Simulated Profits (2.42%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $21.42
1 Year Target Price $21.42
| 3 | Strong Buy |
| 0 | Buy |
| 10 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -22.32% | Avg. Invested days 43 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.28B USD | Price to earnings Ratio 61.66 | 1Y Target Price 21.42 |
Price to earnings Ratio 61.66 | 1Y Target Price 21.42 | ||
Volume (30-day avg) 14 | Beta 1.02 | 52 Weeks Range 14.22 - 23.00 | Updated Date 10/16/2025 |
52 Weeks Range 14.22 - 23.00 | Updated Date 10/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.32 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.11% | Operating Margin (TTM) 7.45% |
Management Effectiveness
Return on Assets (TTM) 2.2% | Return on Equity (TTM) 1.76% |
Valuation
Trailing PE 61.66 | Forward PE 16.81 | Enterprise Value 3903957980 | Price to Sales(TTM) 1.28 |
Enterprise Value 3903957980 | Price to Sales(TTM) 1.28 | ||
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 12.88 | Shares Outstanding 166181720 | Shares Floating 165536935 |
Shares Outstanding 166181720 | Shares Floating 165536935 | ||
Percent Insiders 0.54 | Percent Institutions 119.18 |
Upturn AI SWOT
Envista Holdings Corp
Company Overview
History and Background
Envista Holdings Corp. was founded in 2019 as a spin-off from Danaher Corporation. Its roots, however, trace back to the dental businesses within Danaher. The spin-off aimed to create a more focused and agile company dedicated to dental products and technologies.
Core Business Areas
- Specialty Products & Technologies: Develops, manufactures, and markets a comprehensive range of specialty dental products and technologies, including implants, orthodontics, and biomaterials.
- Equipment & Consumables: Offers a wide array of dental equipment and consumables, such as imaging systems, dental treatment units, and infection prevention products.
Leadership and Structure
Envista Holdings Corp. is led by Amir Aghdaei as CEO. The organizational structure is divided into the two business segments: Specialty Products & Technologies and Equipment & Consumables, each with its own leadership team.
Top Products and Market Share
Key Offerings
- Implant Systems (Nobel Biocare, Straumann competitors): Envista offers various dental implant systems, including the Nobel Biocare brand. Market share varies regionally, but Nobel Biocare is a leading brand with a significant global market share in premium implants. Competitors include Straumann and Dentsply Sirona.
- Orthodontic Solutions (Align Technology, 3M competitors): Envista provides orthodontic solutions through brands like Ormco, including Damon braces and Spark clear aligners. The clear aligner market is dominated by Align Technology (Invisalign), but Envista holds a growing share. Competitors include Align Technology, 3M, and Henry Schein Orthodontics.
- Imaging Systems (Dentsply Sirona, Planmeca competitors): Envista offers dental imaging systems, including cone-beam computed tomography (CBCT) and intraoral scanners. Competitors include Dentsply Sirona, Planmeca, and Carestream Dental.
Market Dynamics
Industry Overview
The dental industry is characterized by technological advancements, an aging population, and increasing demand for cosmetic dentistry. Growth is driven by emerging markets and increasing awareness of oral health. Increasing consolidation and price pressure are also notable trends.
Positioning
Envista Holdings Corp. is positioned as a leading provider of dental products and technologies, with a focus on innovation and premium brands. Its competitive advantage lies in its diversified product portfolio, established distribution network, and strong brand reputation.
Total Addressable Market (TAM)
The global dental market is estimated to be well over $40 billion annually. Envista is positioned to capture a significant portion of this TAM through its broad product portfolio and strong brand presence.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio
- Global distribution network
- Innovation in dental technology
- Diversified product offerings
- Experienced management team
Weaknesses
- Exposure to economic cycles
- Competition in commoditized product segments
- Integration risks associated with acquisitions
- Dependence on key suppliers
- Relatively high debt levels
Opportunities
- Expansion in emerging markets
- Growing demand for cosmetic dentistry
- Adoption of digital dentistry solutions
- Strategic acquisitions to expand product portfolio
- Partnerships with dental service organizations (DSOs)
Threats
- Intense competition from established players
- Technological disruption and obsolescence
- Changes in regulatory requirements
- Economic downturns impacting consumer spending
- Rising material and labor costs
Competitors and Market Share
Key Competitors
- Dentsply Sirona (XRAY)
- Align Technology (ALGN)
- Straumann (STMN.SW - Swiss Exchange, needs conversion into USD)
- 3M (MMM)
- Henry Schein (HSIC)
Competitive Landscape
Envista competes with other major players in the dental industry, facing challenges from both established companies and emerging competitors. Envista aims to differentiate itself through innovation, premium brands, and a strong customer focus.
Major Acquisitions
Carestream Dental's Intraoral Scanner Business
- Year: 2024
- Acquisition Price (USD millions): 600
- Strategic Rationale: Expansion of Envista's digital dentistry solutions portfolio and strengthening its position in the intraoral scanning market.
Nuview
- Year: 2024
- Acquisition Price (USD millions): 250
- Strategic Rationale: Strategic reasons behind the acquisition is expansion of orthodontic portfolio. Enhancing solutions
Growth Trajectory and Initiatives
Historical Growth: Envista's historical growth has been driven by organic growth, acquisitions, and expansion in emerging markets. Financial statements are required to perform such analysis.
Future Projections: Analyst estimates suggest continued growth for Envista, driven by increasing demand for dental products and technologies. Specific projections can be found on financial websites such as Yahoo Finance and Bloomberg.
Recent Initiatives: Recent initiatives include new product launches, strategic acquisitions (listed below), and partnerships with dental service organizations.
Summary
Envista is a solid company operating in the growing dental industry. Its strong brands and global presence provide a good foundation. Increasing competition and integration of acquired companies requires careful management. Continued focus on innovation is crucial for sustained success in the evolving market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Analyst Reports (Yahoo Finance, Bloomberg)
- Industry Publications (Dental Economics, Dentistry Today)
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Data may be delayed and subject to inaccuracies. Consult a financial professional before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envista Holdings Corp
Exchange NYSE | Headquaters Brea, CA, United States | ||
IPO Launch date 2019-09-18 | CEO & Director Mr. Paul A. Keel | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 12300 | Website https://envistaco.com |
Full time employees 12300 | Website https://envistaco.com | ||
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.